Biomarkers Market Research Reports & Industry Analysis
Biomarkers are measurable indicators, such as molecules or genetic mutations, that provide information about a biological process, condition, or disease in the body. As healthcare evolves, it's important to grasp the impact and unique dynamics of this industry. At MarketResearch.com, we understand the need for reliable data on this sector. Our biomarkers market research reports provide a comprehensive and informative analysis, empowering you to navigate this dynamic industry with greater confidence.
Biomarkers Industry Insights
- Our research covers diverse markets so you can quickly and easily find research on segments big and small.
- Through our platform, you can access essential data to drive strategic decisions, from biomarkers market sizing and growth projections to key drivers and challenges.
- Use our research to better understand products under development, market trends, competitor analysis, and leading players.
Harnessing MarketResearch.com's Expertise
For more than twenty years, MarketResearch.com has been a leader in the field of market research, serving a diverse clientele that includes top investment banks, management consulting firms, and multinational corporations. We are known for providing reliable insights and offer a centralized platform with access to reports from numerous firms. In addition, our research specialists are available to provide expert guidance and support every step of the way.
Biomarkers Industry Research & Market Reports
-
Neurological Biomarkers Market Size, Share, and Outlook, 2025 Report- By Type (Genomic, Proteomic, Metabolomic, Imaging, Others), By Application (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Autism Spectrum Disorder, Others), By End-user (Hospital & Hospital Laboratories, Independent clinical diagnostic centers, Research Organizations, Others), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Neurological Biomarkers segments across 22 countries from 2021 to 2032. ... Read More
-
Tumor Profiling Market Size, Share, and Outlook, 2025 Report- By Cancer (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, Others), By Biomarker, Genomic Biomarker, Protein Biomarker), By Technology (Immunoassays, Next-Generation Sequencing, Polymerase Chain Reaction, Mass Spectrometry, In-Situ Hybridization, Microarrays, Others), By Technique (Genomics, Proteomics, Metabolomics, Epigenetics), By Application (Research, Biomarker Discovery, Personalized Medicine, Clinical Application, Diagnostics, Prognostics, Screening, Treatment and Monitoring), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Tumor Profiling segments across 22 countries from 2021 to 2032. ... Read More
-
Global Blood-Based Biomarkers Market Size, By Type (Genetic Biomarkers), By Application (Cancer, Cardiovascular, Neurological Diseases), By Technology (Next-Generation Sequencing, Polymerase Chain Reaction), By End Use, and Regional Forecasts 2022-2032
... due to the rising prevalence of chronic and degenerative diseases, including cancer, cardiovascular diseases, and neurological disorders. The ability of blood-based biomarkers to offer non-invasive, cost-effective, and early disease detection solutions has positioned them as ... Read More
-
Global Behavioral Digital Biomarkers Market Size Study, By Type (Wearable, Mobile-based Applications, Sensors), By Clinical Practice (Diagnostic, Monitoring, Predictive & Prognostic), By End-Use (Healthcare Companies, Providers, Payers), And Regional Forecasts 2022-2032
... in healthcare, enabling the passive collection and analysis of patient data using electronic devices like wearables, mobile applications, and sensors. These digital health technologies track neurological, psychiatric, and metabolic diseases, providing real-time insights into patient ... Read More
-
Epigenetics: Technologies and Global Markets
... formulate growth strategies, evaluate the market landscape, assess their competitive positions and make informed business decisions regarding epigenetics products and services. The scope of epigenetics-targeted therapeutics includes DNA methyltransferase (DNMT) inhibitors, histone deacetylase (HDAC) inhibitors, ... Read More
-
2025 Global Central Nervous System Biomarkers Market Industry (2031 Outlook)
... data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market trends, ... Read More
-
2025 Global Cancer Biomarkers Detection Market Industry (2031 Outlook)
... for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market trends, technology ... Read More
-
2025 Global Clinical Biomarkers Market Industry (2031 Outlook)
... a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market trends, technology analysis, ... Read More
-
Cardiac Biomarkers Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Non-Alcoholic Steatohepatitis Biomarkers Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Global Colorectal Cancer Screening and Diagnostics Market
... regarding each segment. The overview section of the report describes market trends and dynamics, including drivers, challenges, and opportunities. It provides information on emerging technologies and developments in the industry. The report also analyzes critical ... Read More
-
Metabolomics Technologies Market Size, Share, By Technology (Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy, Chromatography, and Other Technologies), By Application (Biomarker And Drug Discovery, Toxicology, Nutrigenomics, Personalized Medicine, and Other Applications), By End-User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, and Agricultural and Environmental Organizations), and By Region - Trends, Analysis and Forecast till 2034
... share, by top players, by type, by the end user, and by region. Metabolomics Technologies Market Size Statistics The metabolomics technologies market size to be Worth USD 51.08 Billion by 2034. The market was valued ... Read More
-
Cardiac Biomarkers Testing Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Cardiac Biomarkers Market, By Product Type (Myocardial Muscle Creatine Kinase, Myoglobin, Troponins, Brain Natriuretic Peptide or NT-proBNP, Ischemia-modified Albumin, and Others), By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others), By Location of Testing (Laboratory Testing and Point of Care Testing), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... over the past few years driven by the rising incidence of cardiovascular diseases and growing elderly population worldwide who are more prone to cardiac issues. Furthermore, ongoing technological advancements are allowing for the development of ... Read More
-
Neurological Biomarkers Market, By Biomarker Type (Artificial Tears, Imaging Biomarkers, Metabolomics Biomarkers, Proteomic Biomarkers, Genomics Biomarkers), By Application (Alzheimers Disease, Parkinsons Disease, Multiple Sclerosis, Autism Spectrum Disorders, Others), By End User (Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... such as Alzheimer's disease, Parkinson's disease, multiple sclerosis and others can boost demand for reliable neurological biomarkers. Furthermore, growing focus on development of precision medicine and companion diagnostics for neurological conditions can drive the market ... Read More
-
Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031
... intervention.” Biomarkers make take the form of cellular characteristics, metabolites (e.g. sugars, lipids and hormones), molecular variations, or physical features (e.g., clinical symptoms) and are assessed accordingly, via measurement, annotation, documents, and images. Increasingly, the ... Read More
-
Global Neurological Biomarkers Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031
... biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus. According to APO Research, The global Neurological Biomarkers market is projected to grow from US$ million in 2025 to US$ million by ... Read More
-
Cardiac Biomarkers Market Report by Type (Troponins (T and I), Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Brain Natriuretic Peptide (BNPs) or NT-proBNP, Ischemia Modified Albumin (IMA), and Others), Location of Testing (Laboratory Testing, Point of Care Testing), Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others), and Region 2025-2033
... Cardiac markers, also known as cardiac biomarkers, are released into the bloodstream when the heart is stressed, or its muscles are damaged. These markers include different types of enzymes, hormones, and proteins, such as cardiac ... Read More
-
Global Biomarkers Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031
... million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for Biomarkers is estimated to increase from $ million in 2025 to reach $ ... Read More
-
DNA Sequencing Products Market Report by Product Type (Consumables and Reagents, Equipments), Application (Biomarkers, Diagnostics, Reproductive Health, Forensics, Personalized Medicine, and Others), End-User (Academic and Government Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Others), and Region 2025-2033
... 2025-2033. The increasing interest in ancestry testing and genealogy, the emergence of cloud-based and AI-driven bioinformatics solutions, the rising integration of DNA sequencing into non-invasive prenatal testing and cancer diagnostics, and the growing collaborations between ... Read More
-
Global Biomarkers Industry Growth and Trends Forecast to 2031
... reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031. North American market for Biomarkers is estimated to increase from $ million in 2025 to reach ... Read More
-
Global Neurological Biomarkers Industry Growth and Trends Forecast to 2031
... biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus. According to APO Research, The global Neurological Biomarkers market was estimated at US$ million in 2025 and is projected to reach a ... Read More
-
Biomarkers: Discovery Techniques and Applications – A Global Market Overview
... can include molecules, genes, proteins, or other substances in tissues, blood, or other body fluids. They are essential in diagnostics, personalized medicine, and drug development by offering insights into health conditions or responses to medical ... Read More
-
Tumor / Cancer Markers
... 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 10.4% CAGR The Tumor / Cancer Markers market ... Read More
-
Renal Biomarkers
... CAGR of 6.5% over the analysis period 2024-2030. Functional Biomarkers, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$1.1 Billion by the end of the analysis ... Read More